Holen Sie sich die Stockscreener-App
215.29
2.69%
-5.96
Handel nachbörslich:
215.00
-0.29
-0.13%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EFX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$221.25
Offen:
$217.89
24-Stunden-Volumen:
1.48M
Relative Volume:
1.31
Marktkapitalisierung:
$27.99B
Einnahmen:
$5.68B
Nettoeinkommen (Verlust:
$604.10M
KGV:
44.57
EPS:
4.83
Netto-Cashflow:
$813.00M
1W Leistung:
-4.03%
1M Leistung:
-11.77%
6M Leistung:
-21.95%
1J Leistung:
-0.42%
1-Tages-Spanne:
$213.55
$221.43
1-Wochen-Bereich:
$213.55
$227.98
52-Wochen-Spanne:
$199.98
$309.63
Equifax Inc Stock (EFX) Company Profile
Firmenname
Equifax Inc
Sektor
Branche
Telefon
(404) 885-8000
Adresse
1550 PEACHTREE ST NW, ATLANTA, GA
Vergleichen Sie EFX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EFX
Equifax Inc
|
215.29 | 27.99B | 5.68B | 604.10M | 813.00M | 4.83 |
|
VRSK
Verisk Analytics Inc
|
284.35 | 41.30B | 2.88B | 958.00M | 920.10M | 6.70 |
|
BAH
Booz Allen Hamilton Holding Corp
|
111.95 | 13.90B | 11.43B | 828.95M | 921.46M | 6.36 |
|
FCN
Fti Consulting Inc
|
165.01 | 6.00B | 3.73B | 312.01M | 434.78M | 8.70 |
|
DGNX
Diginex Ltd
|
104.50 | 2.74B | 0 | 0 | 0 | 0.00 |
Equifax Inc Stock (EFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Fortgesetzt | BofA Securities | Buy |
| 2025-04-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-20 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-14 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2025-02-11 | Herabstufung | Argus | Buy → Hold |
| 2024-12-16 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-01 | Eingeleitet | UBS | Buy |
| 2024-09-19 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-08-13 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-09 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-01-11 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2024-01-08 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-01-04 | Bestätigt | Needham | Buy |
| 2023-12-19 | Eingeleitet | Oppenheimer | Outperform |
| 2023-12-18 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-08 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-11-20 | Eingeleitet | Citigroup | Buy |
| 2023-07-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-11-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2022-10-21 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-10-19 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-04-21 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-30 | Eingeleitet | Deutsche Bank | Hold |
| 2022-03-11 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-31 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-01-27 | Hochstufung | Truist | Hold → Buy |
| 2022-01-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-01-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-10-22 | Hochstufung | Argus | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Neutral |
| 2021-07-08 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2020-12-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-12-11 | Hochstufung | Stifel | Hold → Buy |
| 2020-12-08 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-10-07 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-10-06 | Eingeleitet | Needham | Buy |
| 2020-07-10 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2020-06-09 | Herabstufung | SunTrust | Buy → Hold |
| 2020-05-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2020-04-06 | Herabstufung | Argus | Buy → Hold |
| 2020-03-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-02 | Hochstufung | Exane BNP Paribas | Underperform → Outperform |
| 2020-01-17 | Hochstufung | Argus | Hold → Buy |
| 2019-11-22 | Eingeleitet | Jefferies | Buy |
| 2019-03-15 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2019-02-05 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2018-12-07 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-10-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-04-10 | Eingeleitet | BofA/Merrill | Underperform |
| 2017-12-14 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Equifax Inc Aktie (EFX) Neueste Nachrichten
Earnings Tell The Story For Equifax Inc. (NYSE:EFX) - simplywall.st
Equifax Gears Up to Report Q1 Earnings: What's in the Offing? - TradingView
Equifax (EFX) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
EQUIFAX Earnings Preview: Recent $EFX Insider Trading, Hedge Fund Activity, and More - Nasdaq
Equifax to Settle CFPB Allegations of Inaccurate Credit Reports - PYMNTS.com
Jefferies Adjusts Price Target on Equifax to $260 From $300, Keeps Buy Rating - marketscreener.com
Lobbying Update: $380,000 of EQUIFAX INC lobbying was just disclosed - Nasdaq
Deutsche Bank Adjusts Equifax Price Target to $266 From $268, Maintains Buy Rating - MarketScreener
Redburn Atlantic Adjusts Price Target on Equifax to $245 From $268, Maintains Neutral Rating - MarketScreener
Seeking Clues to Equifax (EFX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance
Xactus First to Offer The Work Number® Report Indicator from Equifax - Morningstar
Earnings Preview: Equifax (EFX) Q1 Earnings Expected to Decline - Yahoo Finance
Equifax Q1 Preview: Management’s Thoughts On Outlook Should Be Interesting (NYSE:EFX) - Seeking Alpha
Wells Fargo Adjusts Equifax Price Target to $284 From $313, Maintains Overweight Rating - marketscreener.com
Equifax Settlement Faces Objection From Watchdog Group - Class Action Lawsuits
Wells Fargo Adjusts Equifax (EFX) Price Target Amid Economic Unc - GuruFocus
Fmr LLC Reduces Holdings in Equifax Inc. (NYSE:EFX) - MarketBeat
Equifax (EFX) Reports on Global Consumer Credit Trends - GuruFocus
Here's Why Investors Must Hold Equifax Stock in Their Portfolios Now - MSN
Equifax Improves Its Google Cloud Marketplace Offerings, and Subprime Lenders Have Much to Gain - BadCredit.org
Equifax Releases 2024 Global Consumer Credit Trends Report | EFX Stock News - GuruFocus
Equifax Releases 2024 Global Consumer Credit Trends Report - PR Newswire
Exclusive: Equifax's $1.5B Tech Investment Uncovers Major Global Credit Shifts - Stock Titan
BofA Reinstates Coverage of Equifax (EFX) with Buy Rating and $2 - GuruFocus
Equifax, NetApp, Omnicom Group, SS&C, and Accenture Shares Are Falling, What You Need To Know - The Globe and Mail
BofA Securities reinstates Equifax with Buy, sets $280 target By Investing.com - Investing.com India
BofA Securities reinstates Equifax with Buy, sets $280 target - Investing.com
Oppenheimer Adjusts Equifax Price Target to $250 From $279, Maintains Outperform Rating - marketscreener.com
ClearStar and Equifax(R) Collaborate to Help Transform Background Checks with Smart Screen(TM) - Morningstar
Equifax outlook revised to stable at S&P on improved leverage By Investing.com - Investing.com Canada
Equifax outlook revised to stable at S&P on improved leverage - Investing.com India
The Rise of US Identity Verification Market: A $21.8 - GlobeNewswire
The Rise of US Identity Verification Market: A $21.8 billion Industry Dominated by Tech Giants - GlobeNewswire Inc.
Equifax (NYSE:EFX) Reaches New 12-Month LowTime to Sell? - MarketBeat
Equifax Price Target Trimmed as Stock Multiple Adjusted to Downside - AskTraders.com
Equifax (NYSE:EFX) Shares Drop 13% Over Week As Governance Simplification Proposal Emerges - Yahoo Finance
What You Need to Know Ahead of Equifax’s Earnings Release - MSN
Barclays cuts Equifax stock rating, price target to $260 - Investing.com Australia
Barclays Downgrades Equifax (EFX) - MSN
Equifax stock touches 52-week low at $213 amid market challenges - Investing.com Canada
Barclays Downgrades Equifax (BMV:EFX) - Nasdaq
Barclays Downgrades Equifax (WBAG:EFX) - Nasdaq
Where Equifax Stands With Analysts - Benzinga
Equifax downgraded to Equalweight at Barclays (EFX:NYSE) - Seeking Alpha
Goldman Sachs Adjusts Price Target on Equifax to $255 From $264, Keeps Neutral Rating - MarketScreener
Barclays cuts Equifax stock rating, price target to $260 By Investing.com - Investing.com South Africa
Analyst recommendations: Dow, Equifax, Goldman Sachs, Bill Holdings… - MarketScreener
Barclays Downgrades Equifax to Equalweight From Overweight, Adjusts Price Target to $260 From $325 - MarketScreener
What You Need To Know Ahead Of Equifax’s Earnings Release - Barchart.com
Equifax Announces Earnings Release Date and Conference Call for First Quarter 2025 Results - WV News
Equifax Sets Key Q1 2025 Earnings Date: What Investors Should Mark on Their Calendar - Stock Titan
Finanzdaten der Equifax Inc-Aktie (EFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):